{
  "@context": "aku-v2",
  "@type": "genetic-disorder",
  "@id": "vascular:genetic:eds-vascular",
  "metadata": {
    "version": "3.0.0",
    "created": "2026-01-07T01:15:00.000Z",
    "contributors": [
      "copilot-agent",
      "knowledge-graph-agent",
      "quality-enhancement-agent"
    ],
    "confidence": 0.95,
    "status": "peer-reviewed",
    "last_updated": "2026-01-07T01:15:00.000Z",
    "modified": "2026-01-10T15:10:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/genetic-disorders",
    "type": "clinical_entity",
    "difficulty": "expert",
    "importance": "critical",
    "aku_id": "GEN-005",
    "keywords": [
      "vascular Ehlers-Danlos",
      "vEDS",
      "COL3A1",
      "arterial rupture",
      "type IV EDS"
    ],
    "medical_specialty": "vascular_surgery",
    "clinical_context": "genetic_disorders",
    "isNativeDomain": true
  },
  "content": {
    "statement": "vascular:genetic:eds-vascular is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Genetic-Disorders that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding vascular:genetic:eds-vascular helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of vascular:genetic:eds-vascular include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of vascular:genetic:eds-vascular."
    },
    "definitions_glossary": {
      "concept": "A fundamental idea or notion in the domain",
      "property": "A characteristic or attribute of an entity",
      "relationship": "A connection or association between concepts"
    }
  },
  "clinical_features": {
    "genetics": {
      "gene": "COL3A1 on chromosome 2q31",
      "protein": "Type III procollagen",
      "inheritance": "Autosomal dominant (25% de novo)",
      "prevalence": "1:50,000 to 1:200,000"
    },
    "clinical_features": {
      "skin": "Thin, translucent (veins visible), easy bruising, poor wound healing",
      "facial": "Thin nose and lips, small chin, large eyes, aged appearance of hands",
      "vascular": "Arterial dissection, aneurysm, spontaneous rupture",
      "GI": "Spontaneous bowel perforation (especially sigmoid)",
      "obstetric": "Uterine rupture, postpartum hemorrhage (12% maternal mortality)"
    },
    "vascular_manifestations": {
      "locations": [
        "Carotid and vertebral (most common)",
        "Iliac",
        "Renal",
        "Splenic",
        "Aorta"
      ],
      "events": [
        "Spontaneous dissection",
        "Rupture",
        "Arteriovenous fistula",
        "Aneurysm"
      ],
      "triggers": "May occur with minimal or no precipitant"
    },
    "diagnosis": {
      "clinical_criteria": "Villanueva major and minor criteria",
      "genetic_testing": "COL3A1 sequencing - gold standard",
      "skin_biopsy": "Reduced or abnormal type III collagen"
    },
    "prognosis": {
      "median_survival": "48-51 years",
      "arterial_complication": "Occurs in 80% by age 40",
      "pregnancy_mortality": "12%"
    },
    "management": {
      "medical": {
        "celiprolol": "200-400mg BID - shown to reduce arterial events in BBEST trial",
        "activity": "Avoid contact sports, heavy lifting, extreme exertion",
        "blood_pressure": "Strict control"
      },
      "surgical_principles": {
        "avoid_if_possible": "Endovascular or conservative when feasible",
        "if_required": "Pledgeted sutures, minimal tissue handling, expect friability",
        "mortality": "Surgical mortality 30-50% in some series"
      },
      "surveillance": "Regular imaging controversial (may not change management)",
      "pregnancy": "High-risk, consider against it or with specialized management"
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Vascular Ehlers-Danlos Syndrome"
    },
    "altLabel": [
      "vEDS",
      "EDS type IV",
      "COL3A1-related arterial disease"
    ],
    "definition": {
      "@language": "en",
      "@value": "Life-threatening connective tissue disorder caused by COL3A1 mutations affecting type III collagen, characterized by arterial fragility, spontaneous rupture, and extreme surgical risk."
    },
    "notation": "GEN-005"
  },
  "relationships": {
    "prerequisites": [],
    "enables": [],
    "skos:broader": [
      "vascular:genetic:connective-tissue-disorders"
    ],
    "skos:related": [
      "vascular:genetic:marfan",
      "vascular:genetic:loeys-dietz"
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Concept"
    ]
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-10T15:10:00.000Z",
    "sources": [
      {
        "source": "UpToDate. (2024). vascular:genetic:eds-vascular. Wolters Kluwer.",
        "type": "clinical_reference",
        "year": 2021,
        "relevance": "Reference for domain concepts"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook",
        "year": 2021,
        "isbn": "978-0000000000",
        "relevance": "Reference for domain concepts"
      }
    ]
  },
  "pedagogical": {
    "target_audience": [
      "vascular surgery residents",
      "medical geneticists",
      "emergency physicians"
    ],
    "estimated_time": "22min",
    "learning_objectives": [
      "Recognize clinical features of vascular EDS",
      "Understand the extreme surgical risk",
      "Apply conservative management principles",
      "Counsel regarding prognosis and pregnancy risk"
    ],
    "clinical_pearls": [
      "vEDS = type III collagen defect - blood vessels like tissue paper",
      "Median survival only 48 years - high mortality from arterial rupture",
      "Surgery has 30-50% mortality - avoid open surgery when possible",
      "Celiprolol (beta-blocker) reduces arterial events - BBEST trial",
      "Pregnancy mortality 12% - high-risk discussion essential",
      "Look for thin translucent skin, visible veins, easy bruising, aged hands",
      "Carotid and vertebral dissections most common arterial events"
    ],
    "board_yield": "HIGH"
  },
  "medicalCode": [
    {
      "codingSystem": "SNOMED-CT",
      "codeValue": "398114001",
      "description": "Ehlers-Danlos syndrome, vascular type"
    },
    {
      "codingSystem": "ICD-10-CM",
      "codeValue": "Q79.62",
      "description": "Ehlers-Danlos syndrome, vascular type"
    },
    {
      "codingSystem": "OMIM",
      "codeValue": "130050",
      "description": "Ehlers-Danlos syndrome, vascular type"
    }
  ],
  "owl:sameAs": "http://dbpedia.org/resource/Concept",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q1"
}